# Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

> **NCT00722969** · PHASE2 · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 48 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** sorafenib + erlotinib

## Key facts

- **NCT ID:** NCT00722969
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** 2008-11
- **Final completion:** 2009-04
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2009-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00722969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00722969, "Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00722969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*